BlackRock Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$19M Buy
371,543
+24,118
+7% +$1.23M 0.02% 563
2016
Q3
$16M Buy
347,425
+112,559
+48% +$5.18M 0.02% 601
2016
Q2
$7.08M Buy
234,866
+114,551
+95% +$3.45M 0.01% 944
2016
Q1
$3.86M Buy
120,315
+1,926
+2% +$61.7K ﹤0.01% 1167
2015
Q4
$6.9M Sell
118,389
-3,267
-3% -$190K 0.01% 983
2015
Q3
$5.15M Sell
121,656
-55,944
-32% -$2.37M 0.01% 1064
2015
Q2
$13M Sell
177,600
-111,317
-39% -$8.13M 0.01% 664
2015
Q1
$14.5M Buy
288,917
+226,641
+364% +$11.4M 0.01% 655
2014
Q4
$2.28M Buy
62,276
+24,526
+65% +$898K ﹤0.01% 1137
2014
Q3
$1.19M Buy
+37,750
New +$1.19M ﹤0.01% 1318